| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
389,580,000 |
| Market
Cap: |
45.17(B) |
| Last
Volume: |
1,813,692 |
Avg
Vol: |
1,929,144 |
| 52
Week Range: |
$75.49 - $140.45 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 487 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems. Co.'s product candidates include Dexcom G7®, which is designed with the goal of carrying forward many of the same features as Co.'s G6 CGM system and adding several new or improved features. Co.'s products include: DexCom G6® integrated Continuous Glucose Monitoring System (G6), which is a type of CGM system to be used as part of an integrated system with other medical devices and electronic interfaces; and DexCom Share®, which transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
64,005 |
267,979 |
302,595 |
574,627 |
| Total Sell Value |
$8,769,441 |
$35,482,928 |
$39,449,301 |
$69,910,840 |
| Total People Sold |
6 |
8 |
13 |
15 |
| Total Sell Transactions |
10 |
24 |
47 |
82 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Doubleday Richard |
EVP Chief Commercial Officer |
• – – |
2019-11-22 |
4 |
AS |
$217.39 |
$333,519 |
I/I |
(1,533) |
15,311 |
|
- |
|
| Abbey Donald |
EVP Quality and Regulatory Aff |
• – – |
2019-11-21 |
4 |
AS |
$218.43 |
$2,555,329 |
D/D |
(11,604) |
68,946 |
|
- |
|
| Augustinos Nicholas |
Director |
– • – |
2019-11-07 |
4 |
AS |
$185.29 |
$223,830 |
D/D |
(1,208) |
6,854 |
|
- |
|
| Sayer Kevin R |
President, CEO and Chairman |
• • – |
2019-11-04 |
4 |
AS |
$156.75 |
$1,575,017 |
D/D |
(10,000) |
212,937 |
|
- |
|
| Doubleday Richard |
EVP Chief Commercial Officer |
• – – |
2019-10-23 |
4 |
AS |
$151.70 |
$233,530 |
I/I |
(1,533) |
16,844 |
|
- |
|
| Pacelli Steven Robert |
EVP Strategy and Corporate Dev |
• – – |
2019-10-23 |
4 |
AS |
$151.69 |
$233,435 |
D/D |
(1,532) |
80,751 |
|
- |
|
| Doubleday Richard |
EVP Chief Commercial Officer |
• – – |
2019-10-07 |
4 |
A |
$0.00 |
$0 |
I/I |
18,377 |
18,377 |
|
- |
|
| Doubleday Richard |
EVP Chief Commercial Officer |
• – – |
2019-10-07 |
4 |
AS |
$0.00 |
$0 |
D/D |
(18,377) |
48,444 |
|
- |
|
| Sayer Kevin R |
President, CEO and Chairman |
• • – |
2019-10-01 |
4 |
AS |
$148.68 |
$1,496,001 |
D/D |
(10,000) |
222,937 |
|
- |
|
| Altman Steven R |
Director |
– • – |
2019-10-01 |
4 |
AS |
$148.83 |
$372,916 |
I/I |
(2,500) |
48,804 |
|
- |
|
| Doubleday Richard |
EVP Chief Commercial Officer |
• – – |
2019-09-24 |
4 |
AS |
$154.80 |
$312,482 |
I/I |
(2,016) |
0 |
|
- |
|
| Pacelli Steven Robert |
EVP Strategy and Corporate Dev |
• – – |
2019-09-23 |
4 |
AS |
$155.11 |
$238,181 |
D/D |
(1,532) |
82,283 |
|
- |
|
| Balo Andrew K |
* |
• – – |
2019-09-18 |
4 |
AS |
$151.46 |
$361,384 |
D/D |
(2,386) |
57,916 |
|
- |
|
| Augustinos Nicholas |
Director |
– • – |
2019-09-16 |
4 |
AS |
$145.49 |
$175,752 |
D/D |
(1,208) |
8,062 |
|
- |
|
| Heller Bridgette P |
Director |
– • – |
2019-09-13 |
4 |
A |
$0.00 |
$3 |
D/D |
3,036 |
3,036 |
|
- |
|
| Moy Jeffrey |
EVP Operations |
• – – |
2019-09-11 |
4 |
A |
$0.00 |
$0 |
I/I |
4,461 |
31,819 |
|
- |
|
| Moy Jeffrey |
EVP Operations |
• – – |
2019-09-11 |
4 |
AS |
$0.00 |
$0 |
D/D |
(4,461) |
30,408 |
|
- |
|
| Blackford Quentin S. |
EVP Chief Financial Officer |
• – – |
2019-09-10 |
4 |
AS |
$139.29 |
$1,457,691 |
D/D |
(10,320) |
69,754 |
|
- |
|
| Leach Jacob Steven |
EVP Chief Technology Officer |
• – – |
2019-09-09 |
4 |
S |
$145.42 |
$706,118 |
D/D |
(4,712) |
111,105 |
|
- |
|
| Abbey Donald |
EVP Quality and Regulatory Aff |
• – – |
2019-09-09 |
4 |
S |
$145.39 |
$875,598 |
D/D |
(5,843) |
80,550 |
|
- |
|
| Ace Heather S |
SVP Human Resources |
• – – |
2019-09-09 |
4 |
AS |
$145.44 |
$970,073 |
D/D |
(6,415) |
52,676 |
|
- |
|
| Blackford Quentin S. |
EVP Chief Financial Officer |
• – – |
2019-09-09 |
4 |
S |
$145.45 |
$1,751,232 |
D/D |
(11,686) |
80,074 |
|
- |
|
| Moy Jeffrey |
SVP Operations |
• – – |
2019-09-09 |
4 |
S |
$145.37 |
$689,475 |
D/D |
(4,601) |
34,869 |
|
- |
|
| Balo Andrew K |
* |
• – – |
2019-09-09 |
4 |
AS |
$145.43 |
$1,380,234 |
D/D |
(9,107) |
60,302 |
|
- |
|
| Murphy Patrick Michael |
SVP Legal Affairs |
• – – |
2019-09-09 |
4 |
S |
$145.48 |
$373,897 |
D/D |
(2,495) |
32,965 |
|
- |
|
2306 Records found
|
|
Page 24 of 93 |
|
|
2.14 (1.88%) 
